vimarsana.com
Home
Live Updates
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results : vimarsana.com
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results
Q2 Fiscal 2024 Highlights
Cash position of $6.6 million as of February 29, 2024Gross profit of $0.5 million, a 22.7% decline over Q1 2024Revenue of $5.0 million, a 15.4% decline over Q1...
Related Keywords
United States
,
Canada
,
Oregon
,
Phoenix
,
Arizona
,
Vancouver
,
British Columbia
,
Utah
,
Canadian
,
America
,
Donna Wong
,
Rick Doblin
,
Donna Wilson
,
Paul Thielking
,
Payton Nyquvest
,
Reid Robison
,
Melony Valleau
,
Nikhil Handa
,
Numinus Clinical Research
,
Numinus Training Program
,
Linkedin
,
Facebook
,
Twitter
,
Psychedelics Drug Development Tracker
,
Numinus Wellness Inc
,
Numinu Cedar Clinical Research
,
Numinus Wellness Clinic Network
,
Company Phoenix
,
Cedar Clinical Research
,
Oregon Health Authority
,
Clinical Trial Application To Health Canada
,
Multidisciplinary Association For Psychedelic Studies
,
Instagram
,
Cedar Clinical
,
Numinus Wellness
,
Clinical Trial Application
,
Health Canada
,
Numinus Founder
,
Numinus Training
,
Multidisciplinary Association
,
Psychedelic Studies
,
Edwin Garner
,
Chief Clinical Officer
,
Numinu Chief Science Officer
,
Chief Medical
,
Numinu Investor Relations
,
Prescription Drug User Fee Act
,
Accessed April
,
Numinu Board
,
Stifel Canada
,
Toll Free North America
,
Markets
,
vimarsana.com © 2020. All Rights Reserved.